tiprankstipranks
Advertisement
Advertisement
NeoGenomics: Solid Clinical Growth and Guidance Raise Offset by Biopharma Weakness, Keeping Risk‑Reward Balanced at Hold
PremiumRatingsNeoGenomics: Solid Clinical Growth and Guidance Raise Offset by Biopharma Weakness, Keeping Risk‑Reward Balanced at Hold
1M ago
NeoGenomics price target raised to $19 from $15 at Needham
Premium
The Fly
NeoGenomics price target raised to $19 from $15 at Needham
1M ago
NeoGenomics: Strong NGS-Driven Momentum Offsetting Strategic and Valuation Concerns, Justifying a Hold Rating
Premium
Ratings
NeoGenomics: Strong NGS-Driven Momentum Offsetting Strategic and Valuation Concerns, Justifying a Hold Rating
1M ago
NeoGenomics Resolves DOJ Investigation, Refocuses on Cancer Care
PremiumCompany AnnouncementsNeoGenomics Resolves DOJ Investigation, Refocuses on Cancer Care
2M ago
NeoGenomics announces settlement of voluntary disclosure to OIG-HHS
Premium
The Fly
NeoGenomics announces settlement of voluntary disclosure to OIG-HHS
2M ago
NeoGenomics price target raised to $19 from $14 at TD Cowen
Premium
The Fly
NeoGenomics price target raised to $19 from $14 at TD Cowen
2M ago
NeoGenomics Announces New Convertible Notes and Share Buyback
PremiumCompany AnnouncementsNeoGenomics Announces New Convertible Notes and Share Buyback
3M ago
NeoGenomics announces pricing of $275M convertible senior notes offering
Premium
The Fly
NeoGenomics announces pricing of $275M convertible senior notes offering
3M ago
NeoGenomics Prices New 2032 Convertible Senior Notes Offering
Premium
Company Announcements
NeoGenomics Prices New 2032 Convertible Senior Notes Offering
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100